ORFLO, a leading supplier of personalized cell & protein analysis instrumentation, is pleased to announce Moxi Flow™; a breakthrough tool for supporting immuno-oncology research.  Moxi Flow’s™ unique combination of impedance (Coulter Principle) and fluorescence flow based detection modes enables gold standard accuracy for counting complex samples such as CAR-T, NK, B, stem, PBMC and other cell types fundamental to immuno-oncology therapeutic approaches.  With the integration of flow, other powerful assays such as in-cell protein quantitation, CRISPR/transfection efficiency checks, apoptosis studies and immune profiles are enabled with industry leading ease of use, affordability, footprint and test times.

Core to the Moxi Flow™ is a patent protected dual use flow cell.  This eliminates many of the challenges associated with traditional flow; cleaning, maintenance, gain setting and cross contamination.  The Moxi Flow™ also enables researchers to conserve their precious samples with 75ul test volume and nearly eliminates all bio hazardous waste.  As little...


Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?